NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JRCT ID: jRCTs021200022

Registered date:01/10/2020

Safety and efficacy of adjuvants in vitrectomy

Basic Information

Recruitment status Recruiting
Health condition(s) or Problem(s) studiedMacular hole
Date of first enrollment01/10/2020
Target sample size60
Countries of recruitment
Study typeInterventional
Intervention(s)Vitrectomy with internal limiting membrane peeling using BBG, ICG and TA as surgical adjuvants

Outcome(s)

Primary OutcomeDisplacement distance of retinal vessel determined by OCT angiography
Secondary OutcomeAssociation of macular displacement with changes in function determined by anorthopia and visual acuity, and morphology determined by retinal and choroidal thickness

Key inclusion & exclusion criteria

Age minimum>= 20age old
Age maximumNot applicable
GenderBoth
Include criteriaCases with macular hole
Exclude criteriaCases who have vitrectomy and whose axial length is more than 27mm

Related Information

Contact

Public contact
Name Takeshi Iwase
Address Akita University,1-1-1,Hondo, Akita Akita Japan 010-8543
Telephone +81-188846167
E-mail tiwase@med.akita-u.ac.jp
Affiliation Akita University Hospital
Scientific contact
Name Takeshi Iwase
Address Akita University,1-1-1,Hondo, Akita Akita Japan 010-8543
Telephone +81-188846167
E-mail tiwase@med.akita-u.ac.jp
Affiliation Akita University Hospital